ACTRN12624000060549已完成Unknown
The impact of dietary FODMAP content on markers of exercise-induced gastrointestinal syndrome in endurance-trained athletes.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •Key inclusion criteria:
- •The Inclusion criteria for the study is healthy male and female recreationally competitive endurance runners 18 – 50 years of age, with pre-existing exercise-associated gastrointestinal symptoms.
- •Only non-pregnant, non-breastfeeding women will participate during day 5 – 10 of the follicular phase of the menstrual cycle confirmed with testing serum estradiol, urinal and calendar-based counting of menstrual diary records (or through a menstrual app) (Gaskell et al, 2020, Snipe et al, 2018). This is to ensure hormonal levels are consistent at each experimental trial, and to reduce any risks that may cause harm to an unborn baby or fluctuations in hormonal levels experienced during breastfeeding.
排除标准
- •Individuals presenting clinical diagnosis of gastrointestinal disease or disorders or individuals presenting any other forms of illness or disease due to confounding effects on gastrointestinal markers/outcomes. Individuals presenting soft tissue injury 1 month prior to participation due to the risk of re-occurrence of injury.
- •Exclusion criteria will be participants who have been following a dietary programme focussed on any changes to the GI function (e.g., a low FODMAP diet, low residue, or fibre-modified diets), or carbohydrate-manipulated diets (i.e., low carbohydrate high fat or ketogenic diets, within the last six months) or have been consuming any potential modifiers or enhancers of the GI integrity (e.g., probiotics, pre-biotics, symbiotic, or antibiotics) in the three months prior to testing. Participants who have a diagnosed food allergy will also be excluded due to potential allergens present in experimental foods or potential cross-contamination with the food manufacturing process of the experimental foods.
- •Participants will also be excluded if they have any GI infections, diseases, or disorders of the GI tract (e.g., IBS, inflammatory bowel disease, coeliac disease, diverticular disease, gastro-oesophageal reflux, or any other self-reported GI issues). If participants have consumed any non-steroidal antiinflammatory or stool-altering medications (e.g., laxatives, anti-diarrhoeal or stool softeners) within one month of the experimental protocols they will be excluded. Participants will also refrain from consuming any of the above whilst on the trial.
研究者
相似试验
已完成
不适用
Food for Irritable Bowel Syndrome. The FIBS studyIrritable Bowel SyndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12611000556943niversity of Otago66
尚未招募
不适用
the effect of gluten on clinical outcomes and quality of life in patients with irritable bowel syndromeIrritable bowel syndrome.Irritable bowel syndromeIRCT20100524004010N29Shahid Beheshti University of Medical Sciences50
已完成
不适用
The effect of glutamine on clinical outcomes, quality of life and intestinal permeability in patients with irritable bowel syndromeIrritable bowel syndromeIRCT20100524004010N28Shahid Beheshti University of Medical Sciences50
尚未招募
Unknown
The effect of a diet with simple carbohydrates on the treatment of infantile colicInfantile colic.Other and unspecified abdominal painR10.4IRCT20230224057517N1Arak University of Medical Sciences110
尚未招募
不适用
Effect of Low FODMAP diet vs restricted FODMAP diet on symptoms and quality of life in irritable bowel syndrome.CTRI/2022/07/043706Sakina Kanchwala